Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.

Home
Find People
Find Everything
About This Site
Annual Report
Export RDF

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.

Kundu AK, Iyer SV, Chandra S, Adhikari AS, Iwakuma T, Mandal TK. Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma. PLoS One. 2017; 12(6):e0179168.

View in: PubMed

subject areas

Bone Neoplasms
Cell Survival
Gene Silencing
Humans
Mutation
Nanoparticles
Osteosarcoma
RNA, Small Interfering
Tumor Cells, Cultured
Tumor Suppressor Protein p53

authors with profiles

Tomoo Iwakuma